Metal abstraction peptide (MAP) tag and associated methods
Compositions comprising a tripeptide having the sequence XC 1 C 2 ; wherein X is any amino acid such that XC 1 C 2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C 1 and C 2 are the same or different; and wherein C 1 and C 2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC 1 C 2 complexes and methods for forming such complexes.
1. A method of increasing aqueous solubility of a peptide by forming a peptide-metal complex with said peptide and a metal atom or ion, said method comprising
a) adding said peptide to a metal-containing composition, wherein said peptide includes a sequence XC 1 C 2 , wherein X is any natural or non-natural amino acid or amino acid analog, and further wherein C 1 and C 2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid;
b) forming a peptide-metal complex between said peptide and a metal atom or ion in said metal-containing composition wherein the metal atom or ion is bound in a square planar or square pyramidal orientation; and
c) formulating said peptide-metal complex into an aqueous composition.
2. The method of claim 1 , wherein said peptide is included in the sequence Z—XC 1 C 2 —Z 1 , wherein Z and Z 1 are each individually any natural or non-atural amino acid or sequence of natural or non-natural amino acids.
3. The method of claim 1 , wherein said peptide is included in the sequence Z—XC 1 C 2 , wherein Z is any natural or non-natural amino acid or sequence of natural or non-natural amino acids.
4. The method of claim 1 , wherein said peptide is included in the sequence XC 1 C 2 —Z 1 , wherein Z 1 is any natural or non-natural amino acid or sequence of natural or non-natural amino acids.
5. The method of claim 1 , wherein C 1 and C 2 are each cysteine.
6. The method of claim 1 , wherein X is chosen from asparagine, glutamine, histidine, lysine, and arginine.
7. The method of claim 1 , wherein said metal-containing composition in step (a) comprises an aqueous solvent.
8. The method of claim 1 , wherein said metal-containing composition in step (a) comprises an organic solvent.
9. The method of claim 1 , wherein said aqueous composition of step (c) is a therapeutic composition.
10. The method of claim 1 , wherein said aqueous composition of step (c) is an imaging composition.
11. The method of claim 1 , wherein said metal-containing composition in step (a) comprises a metal atom or ion attached to a solid substrate or support.
12. The method of claim 1 , wherein said peptide is contained within a polypeptide or protein sequence.
13. The method of claim 12 , wherein said polypeptide or protein sequence is part of an antibody sequence.
14. The method of claim 1 , wherein said metal-containing composition further comprises a chelating agent.
15. The method of claim 14 , wherein said chelating agent is selected from the group consisting of iminodiacetic acid (IDA) and nitrilotriacetic acid (NTA).
16. The method of claim 1 , wherein said peptide is linked to a polypeptide, an antibody, a growth factor, or a carbohydrate.
17. The method of claim 16 , wherein said peptide is linked to an antibody.
18. The method of claim 1 , wherein said metal is selected from the group consisting of a Group 3 metal, a Group 5 metal, a Group 6 metal, a Group 7 metal, a Group 8 metal, a Group 9 metal, a Group 10 metal, a Group 11 metal, a Group 12 metal, a Group 13 metal, a Group 14 metal, and a Group 15 metal.
19. The method of claim 12 , wherein said metal is selected from the group of Group 12 metals consisting of Zn, Cd, and Hg.
20. The method of claim 13 , wherein said metal is Zn.